{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T01:23:37Z","timestamp":1792286617341,"version":"4.4.0"},"reference-count":61,"publisher":"The Company of Biologists","license":[{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"am","delay-in-days":3059,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Summary<\/jats:title><jats:p>In mice, induced global disruption of the Ptpn11 gene, which encodes the SHP-2 tyrosine phosphatase, results in severe skeletal abnormalities. To understand the extent to which skeletal abnormalities can be attributed to perturbation of SHP-2 function in bone-forming osteoblasts and chondrocytes, we generated mice in which disruption of Ptpn11 is restricted to mesenchymal stem cells (MSCs) and their progeny, which include both cell types. MSC-lineage-specific SHP-2 knockout (MSC SHP-2 KO) mice exhibited postnatal growth retardation, limb and chest deformity, and calvarial defects. These skeletal abnormalities were associated with an absence of mature osteoblasts and massive chondrodysplasia with a vast increase in the number of terminally differentiated hypertrophic chondrocytes in affected bones. Activation of mitogen activated protein kinases (MAPKs) and protein kinase B (PKB; also known as AKT) was impaired in bone-forming cells of MSC SHP-2 KO mice, which provides an explanation for the skeletal defects that developed. These findings reveal a cell-autonomous role for SHP-2 in bone-forming cells in mice in the regulation of skeletal development. The results add to our understanding of the pathophysiology of skeletal abnormalities observed in humans with germline mutations in the PTPN11 gene (e.g. Noonan syndrome and LEOPARD syndrome).<\/jats:p>","DOI":"10.1242\/dmm.012849","type":"journal-article","created":{"date-parts":[[2013,9,26]],"date-time":"2013-09-26T03:18:46Z","timestamp":1380165526000},"source":"Crossref","is-referenced-by-count":25,"title":["Deletion of SHP-2 in mesenchymal stem cells causes growth retardation, limb and chest deformity, and calvarial defects in mice"],"prefix":"10.1242","author":[{"given":"Philip E.","family":"Lapinski","sequence":"first","affiliation":[{"name":"University of Michigan Medical School, Ann Arbor, MI, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa F.","family":"Meyer","sequence":"additional","affiliation":[{"name":"University of Michigan Medical School, Ann Arbor, MI, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen-Sheng","family":"Feng","sequence":"additional","affiliation":[{"name":"University of California San Diego,San Diego,CA, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Kamiya","sequence":"additional","affiliation":[{"name":"Texas Scottish Rite Hospital for Children, Dallas, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D.","family":"King","sequence":"additional","affiliation":[{"name":"University of Michigan Medical School, Ann Arbor, MI, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2013,1,1]]},"reference":[{"key":"2021042501123658700_b1-0061448","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm1084","article-title":"Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation","volume":"10","author":"Araki","year":"2004","journal-title":"Nat. Med."},{"key":"2021042501123658700_b2-0061448","doi-asserted-by":"crossref","first-page":"21353","DOI":"10.1074\/jbc.271.35.21353","article-title":"Insulin signaling in mice expressing reduced levels of Syp","volume":"271","author":"Arrandale","year":"1996","journal-title":"J. Biol. Chem."},{"key":"2021042501123658700_b3-0061448","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The molecular understanding of osteoclast differentiation","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"key":"2021042501123658700_b4-0061448","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0969-2126(98)00027-6","article-title":"Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2","volume":"6","author":"Barford","year":"1998","journal-title":"Structure"},{"key":"2021042501123658700_b5-0061448","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1242\/dmm.006130","article-title":"Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations","volume":"4","author":"Bauler","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"2021042501123658700_b6-0061448","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1210\/jc.2005-0995","article-title":"PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome","volume":"90","author":"Binder","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021042501123658700_b7-0061448","doi-asserted-by":"crossref","first-page":"e1002050","DOI":"10.1371\/journal.pgen.1002050","article-title":"Loss-of-function mutations in PTPN11 cause metachondromatosis, but not Ollier disease or Maffucci syndrome","volume":"7","author":"Bowen","year":"2011","journal-title":"PLoS Genet."},{"key":"2021042501123658700_b8-0061448","first-page":"178","article-title":"Many faces of Ras activation","volume":"1786","author":"Buday","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"2021042501123658700_b9-0061448","first-page":"1251","article-title":"The Src homology 2 domain tyrosine phosphatases SHP-1 and SHP-2: diversified control of cell growth, inflammation, and injury","volume":"22","author":"Chong","year":"2007","journal-title":"Histol. Histopathol."},{"key":"2021042501123658700_b10-0061448","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ymgme.2012.04.003","article-title":"Decreased bone mineralization in children with Noonan syndrome: another consequence of dysregulated RAS MAPKinase pathway?","volume":"106","author":"Choudhry","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"2021042501123658700_b11-0061448","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cellsig.2007.10.002","article-title":"The molecular functions of Shp2 in the Ras\/Mitogen-activated protein kinase (ERK1\/2) pathway","volume":"20","author":"Dance","year":"2008","journal-title":"Cell. Signal."},{"key":"2021042501123658700_b12-0061448","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1073\/pnas.1119803109","article-title":"Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature","volume":"109","author":"De Rocca Serra-N\u00e9d\u00e9lec","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042501123658700_b13-0061448","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/341528","article-title":"Grouping of multiple-lentigines\/LEOPARD and Noonan syndromes on the PTPN11 gene","volume":"71","author":"Digilio","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"2021042501123658700_b14-0061448","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ajmg.a.31156","article-title":"LEOPARD syndrome: clinical diagnosis in the first year of life","volume":"140A","author":"Digilio","year":"2006","journal-title":"Am. J. Med. Genet."},{"key":"2021042501123658700_b15-0061448","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1128\/MCB.00646-09","article-title":"Functional effects of PTPN11 (SHP2) mutations causing LEOPARD syndrome on epidermal growth factor-induced phosphoinositide 3-kinase\/AKT\/glycogen synthase kinase 3beta signaling","volume":"30","author":"Edouard","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"2021042501123658700_b16-0061448","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/humu.20005","article-title":"Noonan syndrome-associated SHP2\/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2\/MAPK1 activation","volume":"23","author":"Fragale","year":"2004","journal-title":"Hum. Mutat."},{"key":"2021042501123658700_b17-0061448","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/archpedi.1969.02100030654006","article-title":"Multiple lentigenes syndrome","volume":"117","author":"Gorlin","year":"1969","journal-title":"Am. J. Dis. Child."},{"key":"2021042501123658700_b18-0061448","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1038\/sj.onc.1203655","article-title":"Shp-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt","volume":"19","author":"Hakak","year":"2000","journal-title":"Oncogene"},{"key":"2021042501123658700_b19-0061448","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.febslet.2006.03.088","article-title":"Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3K binding on Gab1","volume":"580","author":"Hanna","year":"2006","journal-title":"FEBS Lett."},{"key":"2021042501123658700_b20-0061448","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.1073\/pnas.1213000110","article-title":"Nonreceptor tyrosine phosphatase Shp2 promotes adipogenesis through inhibition of p38 MAP kinase","volume":"110","author":"He","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2021042501123658700_b21-0061448","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1754-4505.1989.tb01188.x","article-title":"The occurrence of supernumerary teeth with isolated, nonfamilial leopard (multiple lentigines) syndrome: report of case","volume":"9","author":"Ho","year":"1989","journal-title":"Spec. Care Dentist."},{"key":"2021042501123658700_b22-0061448","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0092-8674(00)80938-1","article-title":"Crystal structure of the tyrosine phosphatase SHP-2","volume":"92","author":"Hof","year":"1998","journal-title":"Cell"},{"key":"2021042501123658700_b23-0061448","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ajmg.a.30598","article-title":"Genotypic and phenotypic characterization of Noonan syndrome: new data and review of the literature","volume":"134A","author":"Jongmans","year":"2005","journal-title":"Am. J. Med. Genet. A."},{"key":"2021042501123658700_b24-0061448","doi-asserted-by":"crossref","first-page":"30984","DOI":"10.1074\/jbc.M504699200","article-title":"Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes","volume":"280","author":"Keilhack","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021042501123658700_b25-0061448","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1148\/radiology.148.1.6602353","article-title":"Metachondromatosis","volume":"148","author":"Kennedy","year":"1983","journal-title":"Radiology"},{"key":"2021042501123658700_b26-0061448","doi-asserted-by":"crossref","DOI":"10.1097\/BRS.0b013e3182a3d370","article-title":"Induction of SHP2-deficiency in chondrocytes causes severe scoliosis and kyphosis in mice","author":"Kim","year":"2013","journal-title":"Spine"},{"key":"2021042501123658700_b27-0061448","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2062","article-title":"Targeted disruption of Shp2 in chondrocytes leads to metachondromatosis with multiple cartilaginous protrusions","volume-title":"J. Bone Miner. Res.","author":"Kim","year":"2013"},{"key":"2021042501123658700_b28-0061448","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1365-2443.2008.01209.x","article-title":"PI3K\/Akt signaling as a key regulatory pathway for chondrocyte terminal differentiation","volume":"13","author":"Kita","year":"2008","journal-title":"Genes Cells"},{"key":"2021042501123658700_b29-0061448","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1128\/MCB.24.12.5340-5352.2004","article-title":"SHP-2 positively regulates myogenesis by coupling to the Rho GTPase signaling pathway","volume":"24","author":"Kontaridis","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"2021042501123658700_b30-0061448","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.M513068200","article-title":"PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects","volume":"281","author":"Kontaridis","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2021042501123658700_b31-0061448","first-page":"1495","article-title":"Spinal deformities in Noonan syndrome: a clinical review of sixty cases","volume":"83-A","author":"Lee","year":"2001"},{"key":"2021042501123658700_b32-0061448","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/jmg.39.8.571","article-title":"PTPN11 mutations in LEOPARD syndrome","volume":"39","author":"Legius","year":"2002","journal-title":"J. Med. Genet."},{"key":"2021042501123658700_b33-0061448","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1210\/jc.2005-0983","article-title":"Noonan syndrome: relationships between genotype, growth, and growth factors","volume":"91","author":"Limal","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021042501123658700_b34-0061448","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/gene.10092","article-title":"Expression of Cre Recombinase in the developing mouse limb bud driven by a Prxl enhancer","volume":"33","author":"Logan","year":"2002","journal-title":"Genesis"},{"key":"2021042501123658700_b35-0061448","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1126\/science.285.5429.895","article-title":"Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase","volume":"285","author":"Maekawa","year":"1999","journal-title":"Science"},{"key":"2021042501123658700_b36-0061448","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI44972","article-title":"Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation","volume":"121","author":"Marin","year":"2011","journal-title":"J. Clin. Invest."},{"key":"2021042501123658700_b37-0061448","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/hmg\/ddn099","article-title":"Diverse driving forces underlie the invariant occurrence of the T42A, E139D, I282V and T468M SHP2 amino acid substitutions causing Noonan and LEOPARD syndromes","volume":"17","author":"Martinelli","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"2021042501123658700_b38-0061448","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000342251","article-title":"LEOPARD syndrome: clinical features and gene mutations","volume":"3","author":"Mart\u00ednez-Quintana","year":"2012","journal-title":"Mol. Syndromol."},{"key":"2021042501123658700_b39-0061448","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/j.1349-7006.2009.01257.x","article-title":"Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation","volume":"100","author":"Matozaki","year":"2009","journal-title":"Cancer Sci."},{"key":"2021042501123658700_b40-0061448","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1128\/MCB.01549-08","article-title":"Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis","volume":"29","author":"Matsushita","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"2021042501123658700_b41-0061448","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1128\/MCB.01401-09","article-title":"Selective signaling by Akt2 promotes bone morphogenetic protein 2-mediated osteoblast differentiation","volume":"30","author":"Mukherjee","year":"2010","journal-title":"Mol. Cell. Biol."},{"key":"2021042501123658700_b42-0061448","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11154-006-9021-1","article-title":"Noonan syndrome and related disorders: alterations in growth and puberty","volume":"7","author":"Noonan","year":"2006","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"2021042501123658700_b43-0061448","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ajmg.a.20502","article-title":"Adult height in Noonan syndrome","volume":"123A","author":"Noonan","year":"2003","journal-title":"Am. J. Med. Genet. A."},{"key":"2021042501123658700_b44-0061448","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/EJE-08-0413","article-title":"Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11","volume":"159","author":"Noordam","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"2021042501123658700_b45-0061448","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1074\/jbc.275.5.3577","article-title":"Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop","volume":"275","author":"Ohashi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2021042501123658700_b46-0061448","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cyto.2011.10.006","article-title":"IL-4 acts as a potent stimulator of IFN-\u03b3 expression in CD8+ T cells through STAT6-dependent and independent induction of Eomesodermin and T-bet","volume":"57","author":"Oliver","year":"2012","journal-title":"Cytokine"},{"key":"2021042501123658700_b47-0061448","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1101\/gad.1089403","article-title":"Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2","volume":"17","author":"Peng","year":"2003","journal-title":"Genes Dev."},{"key":"2021042501123658700_b48-0061448","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1136\/jmg.2003.013466","article-title":"Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome","volume":"41","author":"Sarkozy","year":"2004","journal-title":"J. Med. Genet."},{"key":"2021042501123658700_b49-0061448","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/74279","article-title":"The SH2 tyrosine phosphatase shp2 is required for mammalian limb development","volume":"24","author":"Saxton","year":"2000","journal-title":"Nat. Genet."},{"key":"2021042501123658700_b50-0061448","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1093\/emboj\/16.9.2352","article-title":"Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2","volume":"16","author":"Saxton","year":"1997","journal-title":"EMBO J."},{"key":"2021042501123658700_b51-0061448","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"2021042501123658700_b52-0061448","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/adc.67.2.178","article-title":"A clinical study of Noonan syndrome","volume":"67","author":"Sharland","year":"1992","journal-title":"Arch. Dis. Child."},{"key":"2021042501123658700_b53-0061448","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/340847","article-title":"PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity","volume":"70","author":"Tartaglia","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"2021042501123658700_b54-0061448","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/499925","article-title":"Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease","volume":"78","author":"Tartaglia","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"2021042501123658700_b55-0061448","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat. Genet."},{"key":"2021042501123658700_b56-0061448","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000276766","article-title":"Noonan syndrome: clinical aspects and molecular pathogenesis","volume":"1","author":"Tartaglia","year":"2010","journal-title":"Mol. Syndromol."},{"key":"2021042501123658700_b57-0061448","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1038\/sj.onc.1204699","article-title":"The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase\/Akt activation by growth factors","volume":"20","author":"Wu","year":"2001","journal-title":"Oncogene"},{"key":"2021042501123658700_b58-0061448","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nature12396","article-title":"Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling","volume":"499","author":"Yang","year":"2013","journal-title":"Nature"},{"key":"2021042501123658700_b59-0061448","doi-asserted-by":"crossref","first-page":"10472","DOI":"10.1074\/jbc.M113.450023","article-title":"Structural and mechanistic insights into LEOPARD syndrome-associated SHP2 mutations","volume":"288","author":"Yu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"2021042501123658700_b60-0061448","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jpeds.2003.11.032","article-title":"Genotype-phenotype correlations in Noonan syndrome","volume":"144","author":"Zenker","year":"2004","journal-title":"J. Pediatr."},{"key":"2021042501123658700_b61-0061448","doi-asserted-by":"crossref","first-page":"16064","DOI":"10.1073\/pnas.0405041101","article-title":"Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism","volume":"101","author":"Zhang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/6\/6\/1448\/1865967\/1448.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.012849\/2035527\/dmm_012849.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.012849\/2035527\/dmm_012849.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T21:02:40Z","timestamp":1688504560000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/doi\/10.1242\/dmm.012849\/258776\/Deletion-of-SHP-2-in-mesenchymal-stem-cells-causes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,1]]},"references-count":61,"URL":"https:\/\/doi.org\/10.1242\/dmm.012849","relation":{},"ISSN":["1754-8411","1754-8403"],"issn-type":[{"value":"1754-8411","type":"electronic"},{"value":"1754-8403","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,1]]},"article-number":"dmm.012849"}}